H.R. 1563
IntroducedSTOP Fentanyl and Xylazine Act
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately by AI, and any passage it quotes is checked against the bill text before it can be shown. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 1563 Introduced in House (IH)]
<DOC>
119th CONGRESS 1st Session H. R. 1563
To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 25, 2025
Ms. Crockett (for herself and Mr. Gooden) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act'' or the ``STOP Fentanyl and Xylazine Act''.
SEC. 2. CLARIFICATION REGARDING THE TREATMENT OF EQUIPMENT THAT INDICATES THE PRESENCE OF FENTANYL OR XYLAZINE IN A COMPOUND.
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following:
``(g) Clarification.--This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.''. <all>